Inherited neurological disorders are generally relatively uncommon (Table 18 .1).Their frequency in Africa is largely unknown. Inheritance follows the basic Mendelian laws for autosomal dominant, autosomal recessive and X-linked recessive inheritance. An example of an autosomal dominant disorder is neurofibromatosis and of an autosomal recessive disorder is Friedreich's ataxia. Duchenne's and Becker's muscular dystrophy (Chapter 13) are both X-linked disorders. Huntington's disease is an example of an autosomal dominant and a trinucleotide repeat disorder. A positive family history can usually be elicited in the autosomal dominant and X-linked disorders, underlining the importance of the family history. The aim of this chapter is to review the more commonly encountered hereditary neurological disorders. The student should aim to recognize and be familiar with the main ones. 
NEUROFIBROMATOSIS TYPE 1
Neurofibromatosis type 1 is an autosomal dominant disorder with an age-dependent penetrance caused by a defect in the NF1 gene (neurofibromin) on chromosome 17q occurring with a frequency of about 1 in 4-5,000 ( Fig. 18.1 ). They are also at risk for large deforming plexiform neuromas ( Fig. 18.1) , sarcomas, brain gliomas and pheochromocytoma. 
NEUROFIBROMATOSIS TYPE 2
Neurofibromatosis type 2 is a much rarer autosomal dominant disorder affecting about 1 in 50,000 due to a defect in the NF2 gene (merlin) on chromosome 22. It is characterised by few skin manifestations and the development of intracranial tumours, acoustic neuromas (vestibular Schwannoma) ( Fig. 18 .2) and meningiomas; see diagnostic criteria (Table 18. 3). Deafness due to an acoustic neuroma involving the eighth cranial nerve is the main clinical presentation of type 2. This is usually accompanied by tinnitus, vertigo, ataxia, facial numbness and weakness.
The clinical features at presentation are usually unilateral although the acoustic neuromas are commonly bilateral on neuroimaging. The diagnosis is confirmed by neuroimaging of the brain, usually MRI ( Fig. 18 .2). Management is either conservative by observation only or with deep X-ray therapy (DXT), or surgery for the tumours where possible. Genetic counselling is a very important part of management. 
STURGE WEBER SYNDROME
This is an uncommon sporadic disorder affecting 1/50,000 in high income countries. It is a neurocutaneous syndrome characterized by a port wine staining affecting one half of the face (Fig. 18 .4) usually in a V1 distribution and associated neurological abnormalities. The defining characteristic of the syndrome is an underlying intracranial vascular abnormality in the leptomeninges affecting the cortical regions of the hemispheres. The syndrome includes seizures, glaucoma, headaches, behavioural problems and stroke like episodes. It has its onset usually in early childhood and is usually progressive. However the clinical course is highly variable and it is important to note that not all children or adults with the characteristic port wine facial staining have the syndrome. Neuroimaging, usually CT confirms the presence of intracerebral calcifications affecting the parietal or occipital lobes on the affected side but they can be generalised. Management is largely symptomatic and supportive.
SPINOCEREBELLAR DISORDERS
These represent a wide but rare group of disorders with progressive cerebellar degeneration in combination with other neurological findings. Friedreich's ataxia is one of the main early onset ataxias.
FRIEDREICH'S ATAXIA
Friedreich's ataxia is an autosomal recessive condition caused by mutations in the FDRA gene (frataxin) on chromosome 9, mostly trinucleotide (GAA) repeat expansions (67-1700). It affects 1/50,000 with its onset usually in young persons under the age of 20 years (average 15.5 years with a range of 2-51 years). The severity of the disease depends on the number of abnormal trinucleotide repeats. The disease is characterized by progressive degeneration of the main cerebellar tracts with involvement of the corticospinal and posterior columns. The main clinical feature is gait ataxia which progressively worsens and may be accompanied by pyramidal findings and peripheral neuropathy (absent ankle jerks). Other less frequent findings include optic atrophy and deafness. There may be a scoliosis, pes cavus, diabetes mellitus and an associated cardiomyopathy as evidenced by widespread T inversion on ECG.
There is no treatment for the underlying genetic condition and management is mainly supportive and treatment of complications. The differential diagnosis includes the other hereditary cerebellar ataxias which are mainly the later onset type (>20 yrs) and are mostly 
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INHERITED NEUROPATHIES
These are also called the hereditary motor sensory neuropathies (HMSN). Charcot-MarieTooth disease (CMT1 = HMSN1) or peroneal muscular atrophy is the most common example in clinical practice. It is an autosomal dominant disorder, mostly due to 1, 5 Mb duplication, involving the PMP22 gene on chromosome 17p. It affects about 1/3000 and the age of awareness of the disorder ranges from childhood to middle age, although it is already established in childhood but is subclinical. Patients present with a chronic distal wasting of the lower limbs (Fig. 18 .5) which progresses very slowly over many years. Typically there is marked wasting of the calf and distal thigh muscles with bilateral pes cavus (high arched feet with clawed toes), reflexes are lost as may be distal sensation. When wasting is severe the leg is said to resemble an inverted champagne bottle with a long neck. This may be accompanied by wasting of forearms and clawing of the hands in about a third of patients ( Fig. 18.5 ). The level of disability is less than expected for the degree of wasting.
There is no specific treatment for inherited neuropathies. Nerve conduction studies show severe slowing of motor conduction velocities consistent with neuropathy. The differential diagnosis includes other long standing neuropathies including leprosy and less common forms of hereditary neuropathies. These rarer forms of hereditary neuropathies may be accompanied by signs of spastic paraparesis, deafness, optic atrophy and retinitis pigmentosa.
HUNTINGTON'S DISEASE (HD)
This is an autosomal dominant inherited neurodegenerative disorder, affecting particularly the caudate nucleus and presenting in middle age with choreaform movements, progressive dementia and psychiatric symptoms. There is usually a positive family history. It affects about 1 in 10,000 persons and the causative gene lies on chromosome 4. It is an example of The diagnosis can be confirmed by diagnostic genetic testing, if available. Concerned relatives at risk need to be counselled carefully before presymptomatic or predictive DNA testing is performed. There is no effective treatment but the chorea and the anxiety may respond to treatment early on in the disease. If the patient's chorea is symptomatic tetrabenazine can be effective but parkinsonism and depression are adverse effects. Benzodiazepines can be used for anxiety and low dose haloperidol (0.5 mg bd) for aggression.
OTHER HEREDITARY NEUROLOGICAL DISORDERS

Muscular disorders
The main inherited myopathies are the dystrophies, Duchenne's (DMD), Becker's (BMD), limb girdle (LGMD), facioscapulohumeral (FSHD) and myotonic dystrophy. These are presented in chapter 13.
HEREDITARY SPASTIC PARAPARESIS (HSP)
This is an uncommon form of hereditary spastic paraparesis that usually follows an inheritance pattern of autosomal dominance and less frequently recessive and X-linked. Several genetic mutations occur involving over 20 different loci on different chromosomes with the spasmin gene on chromosome 2p22 accounting for 40-50% of cases. Two main age groups are affected, the more common one <35 yrs and the other with later onset (40-60 yrs) although the onset can be at any age. The time course is usually one of slow progression over many years.
The most common clinical phenotype is usually that of a slowly progressive spastic paraparesis beginning in childhood or teens characterized by hyperreflexia and up going toes with increasing difficulty in walking. If it occurs in childhood there may be pes cavus or arched feet coupled with tightening of the calf muscles which may result in heel-toe walking. Bladder and bowel function are not usually directly affected. The upper limbs are variably affected. HSP can occur in conjunction with other neurological abnormalities. These include cerebellar, optic atrophy, peripheral neuropathy, ocular palsies, macular degeneration and retardation and dementia.
The differential diagnosis includes the main causes of chronic spastic paraparesis in Africa including cord compression, primary lateral sclerosis, Konzo and HTLV-1. Management is by genetic counselling and the paraplegia measures already outlined in chapter 10.
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